Staidson (Beijing) Biopharmaceuticals Co., LTD.

Business Scope：Production of tablet, hard capsule, powder therapeutic biological products (mouse nerve growth factor for injection), oral solution (drug production license valid until December 13, 2020): Pharmaceutical technology development, biological products development; Import and export of goods, agent import and export, technology import and export. Market subjects independently choose business items and carry out business activities according to law; For projects subject to approval according to law, business activities shall be carried out according to approved contents after being approved by relevant departments: business activities of projects prohibited and restricted by national and municipal industrial policies shall not be carried out.